Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV
· Real-Time Price · USD
1.05
0.02 (1.94%)
At close: Jun 17, 2025, 2:22 PM
1.94% (1D)
| Bid | 1.04 |
| Market Cap | 25.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.01M |
| EPS (ttm) | -0.66 |
| PE Ratio (ttm) | -1.59 |
| Forward PE | -1.51 |
| Analyst | Strong Buy |
| Ask | 1.05 |
| Volume | 27,330 |
| Avg. Volume (20D) | 64,458 |
| Open | 1.00 |
| Previous Close | 1.03 |
| Day's Range | 1.00 - 1.06 |
| 52-Week Range | 0.81 - 1.76 |
| Beta | 0.74 |
About ENLV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENLV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENLV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+20.37%
Elivex Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
-5.24%
Enlivex Therapeutics shares are trading higher after the company announced its board approved the purchase of up to $1 million in Bitcoin.
